
Laparoscopic Insufflation Devices Market Outlook (2021-2031)
No. of Pages: 200 | Report Code: BMIPUB00031678 | Category: Life Sciences
No. of Pages: 200 | Report Code: BMIPUB00031678 | Category: Life Sciences
The laparoscopic insufflation devices market size is expected to reach US$ 2,000.74 million by 2031 from US$ 1,109.27 million in 2024. The market is estimated to record a CAGR of 8.8% from 2025 to 2031.
The global laparoscopic insufflation devices market is experiencing significant growth driven by growth in laparoscopic bariatric surgeries, technological innovation in gas regulation, and emphasis on patient comfort during procedures. These insufflation devices are vital for both establishing but also maintaining working space within the body cavity (abdomen in the case of laparoscopic surgery) during a minimally invasive surgical approach. This is done by pumping medical gas, normally C02, directly into the site of surgery which is required for visibility as well as access to surgical instruments. Insufflation devices are required for every laparoscopic case, and their role is fundamentally important as it supports nearly every minimally invasive procedure and process relies on an optimal insufflation process.
The advances in insufflation technology especially for "smart" insufflation devices have advanced better pressure control, better flow rates and better safety in high-flow insufflators, for example Stryker's Pneumo Sure was vitally important in those bariatric Surgery cases, as well as procedures that had a great deal of tool swapping. The benefit is the pneumoperitoneum will remain constant despite the amount of CO wide escape via leaking instruments into the abdomen, and it would get to a preset pressures 20-30% faster in a few bench tests compared to a standard insufflator. The continued development of insufflation devices, this is due to the emphasis placed on their ability to allow for safer, effective and precise laparoscopic procedures keeps them relevant to modern day surgery.
Laparoscopic Insufflation Devices Market Strategic Insights
Laparoscopic Insufflation Devices Market Segmentation Analysis
Key segments that contributed to the derivation of the laparoscopic insufflation devices market analysis are product, application, and end user.
The increasing number of bariatric laparoscopic surgeries is driving the laparoscopic insufflation devices market. The rise in obesity worldwide has coincided with an increase in demand for weight-loss procedures, such as sleeve gastrectomy, gastric bypass, and adjustable gastric banding, all of which are often laparoscopic procedures. There are limitations to the variability of abdominal cavities exposed to laparoscopic camera tips, which means that laparoscopic surgeons depend on consistent insufflation to inflate the abdominal cavity, ideally with carbon dioxide, and maintain a sufficiently stable and clear operative field in which to operate.
Consequently, there is a growing demand for high-performance insufflation devices that provide controlled pressure and flow, integrated smoke evacuation, and ideally, temperature regulation. In addition, being minimally invasive, and causing less pain than an open procedure, is driving the need for advanced laparoscopic systems. Examples of minimally invasive benefits are shorter periods of postoperative pain, less hospitalization fluid and food requirements, and faster recovery. This trend is influencing emerging markets with extensive development plans that will improve healthcare capacity and use of technology to tackle the obesity crisis. It also influences developed markets. The sum of these emerging and established market factors contributes to consistent growth in the insufflation device segment.
Integrated insufflation and smoke evacuation systems represent a major opportunity in the laparoscopic insufflation devices segment. Most traditional laparoscopic procedures use a traditional insufflation unit and a separate smoke evacuation unit. Separate systems complicate workflow, increase equipment costs, and take up additional operating room (OR) space. Integrated insufflation and smoke evacuation were developed to help mitigate the complication of having two separate units for insufflation and smoke evacuation. Moreover, many integrated insufflation units offer gas heating and humidification, offering stepwise improvement of the insufflation process.
Integrated insufflation and smoke evacuation systems streamline the surgical preparation and contribute to system efficiency and safety by maintaining a constant pneumoperitoneum and constant removal of surgical smoke, which can potentially obscure the field of view and cause harm operating room team. As minimally invasive surgeries become more advanced and widely adopted, demand for such multifunctional, user-friendly devices is growing. Surgeons and health care institutions want to improve ergonomics, reduce operative time, and improve patient outcomes – these all benefits are provided through integrated insufflation-evacuation units, which will provide opportunity in the laparoscopic insufflation device marketplace.
The laparoscopic insufflation devices market is classified according to products into CO₂ insufflators, warm gas insufflators, and insufflation tubing and accessories. The CO₂ insufflators segment led the market in 2024 and beyond. CO₂ insufflators dominate the market as they are the standard choice for laparoscopic procedures due to their efficiency in creating a stable and safe pneumoperitoneum. Carbon dioxide is preferred because it is non-flammable, readily absorbed by the body, and easy to control, which reduces the risk of gas embolism and other complications. The widespread use of CO₂ in minimally invasive surgeries has solidified its position as the leading product type in this market.
In terms of applications, the market is segmented into general surgery, bariatric surgery, gynecological surgery, colorectal surgery, others. The bariatric surgery segment had the largest market share in 2024. Bariatric surgery represents the major application segment for laparoscopic insufflation devices, driven by the global rise in obesity and the increasing adoption of minimally invasive weight-loss procedures. Surgeries like laparoscopic sleeve gastrectomy and gastric bypass require effective insufflation to provide clear visualization and access within the abdominal cavity. As the demand for safe, efficient bariatric procedures grows, so does the reliance on high-performance insufflation systems.
By end user, the market is segmented into hospitals and clinics, and ambulatory surgical centers. The hospitals and clinics segment held the largest share of the market in 2024. Due to a high surgical volume and well-developed framework for minimally invasive procedures, hospitals and clinics are the primary laparoscopic insufflation device users. These facilities are equipped with advanced operating rooms and operating room staff, trained personnel, enabling the integration of sophisticated insufflation technologies. Their capacity to invest in high-end equipment and the need to ensure procedural safety and efficiency make them the dominant segment in this market.
Laparoscopic Insufflation Devices Market Report Highlights
Report Attribute
Details
Market size in 2024
US$ 1,109.27 Million
Market Size by 2031
US$ 2,000.74 Million
Global CAGR (2025 - 2031)
8.8%
Historical Data
2021-2023
Forecast period
2025-2031
Segments Covered
By Product
By Application
By End User
Regions and Countries Covered
North America
Europe
Asia-Pacific
South and Central America
Middle East and Africa
Market leaders and key company profiles
The "Laparoscopic Insufflation Devices Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
The geographical scope of the laparoscopic insufflation devices market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. The laparoscopic insufflation devices market in Asia Pacific is expected to grow significantly during the forecast period.
The Asia Pacific laparoscopic insufflation devices market consists of China, Japan, India, South Korea, Australia, Bangladesh, New Zealand, Philippines, Singapore, Indonesia, Taiwan, Malaysia, Vietnam, and the Rest of Asia Pacific. In the Asia Pacific region, the market for laparoscopic insufflation devices is the fastest growing overall, spurred by rapid improvements in healthcare infrastructure, higher rates of patients choosing minimally invasive surgeries, and increased awareness among patients and providers. China is leading the charge, with hospital installations of robotic-assisted systems exceeding 300 and volumes of laparoscopic surgeries growing rapidly year-on-year. Continued government support to increase surgical care and to promote locally manufactured medical devices has also bolstered adoption. In India, the increased prevalence of obesity and other non-communicable diseases (NCDs), along with an increasing number of gastrointestinal disorders, has resulted in increases in the number of laparoscopic procedures being performed, with institutions such as AIIMS and Apollo Hospitals incorporating advanced insufflation systems into their surgical suites. Japan's aging population, combined with the relatively high number of procedures involving laparoscopic colorectal surgery and gynecologic surgery, has resulted in ongoing strong growth, fuelled largely by the country's highly sophisticated medical infrastructure. South Korea has been a world leader in medical technology, has been similarly expanding the quantity of insufflation device capabilities under a national mandate for minimally invasive patient care.
The laparoscopic insufflation devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the laparoscopic insufflation devices market are:
The Laparoscopic Insufflation Devices Market is valued at US$ 1,109.27 Million in 2024, it is projected to reach US$ 2,000.74 Million by 2031.
As per our report Laparoscopic Insufflation Devices Market, the market size is valued at US$ 1,109.27 Million in 2024, projecting it to reach US$ 2,000.74 Million by 2031. This translates to a CAGR of approximately 8.8% during the forecast period.
The Laparoscopic Insufflation Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Laparoscopic Insufflation Devices Market report:
The Laparoscopic Insufflation Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Laparoscopic Insufflation Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Laparoscopic Insufflation Devices Market value chain can benefit from the information contained in a comprehensive market report.